Bussum, Netherlands, July 4, 2011: Seventeen Bentham Science Journals improved their impact factors(click here) rankings, according to recently released Journal Citation Reports® 2010. Two new journals, Anti Cancer Agents in Medicinal Chemistry and Recent Patents on Nanotechnology, registered impact factors for the first time reflecting the high quality of research published by Bentham Science.
Current Molecular Medicine topped the Bentham Science Impact factor list with an increase in impact factor to 5.212. Other important journals which gained impact factor were:
1. Current Alzheimer Disease (IF: 4.953)
2. Current Gene Therapy (IF: 4.902)
3. Current Cancer Drug Targets (IF: 4.771)
4. Current Pharmaceutical Design (IF: 4.774)
5. Current Medicinal Chemistry (IF: 4.63)
6. Current Topics in Medicinal Chemistry (IF: 4.112)
Journal Citation Reports (JCR) is the most authentic information resource about scholarly journals published in various disciplines. It compiles results by critically evaluating the world's leading journals, with quantifiable, statistical information based on citation data. This report is published annually by the Institute of Scientific Information, a division of Thomson Reuters.
Bentham Science Publishers now publishes 106 print and online scholarly journals along with over 200 open access publications. Major fields covered by the journals published by Bentham Science Publishers includes science, technology, medicine, engineering, chemistry, life sciences and pharmaceutical science,. Bentham's journals have a large distribution and readership particularly in Europe, North America, Japan and Asia. For a detailed profile see website http://www.benthamscience.com